At present, the literature on the inhibitory effect of metformin on glioma stem cells mainly focuses on the studies on the AMPK-mTOR/STAT3, AMPK-FOXO3 and AMPK-P13K/AKT pathways of MET (Figure 3). Here, MET is linked to central nervous system cancer.